PortalPublikationenAddition of cyclophosphamide on insufficient response to pom...

Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial

Standard

Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial. / Weisel, Katja C; Scheid, Christof; Zago, Manola; Besemer, Britta; Mai, Elias K; Haenel, Mathias; Duerig, Jan; Munder, Markus; Lindemann, Hans-Walter; Seckinger, Anja; Kunz, Christina; Benner, Axel; Hose, Dirk; Jauch, Anna; Salwender, Hans; Goldschmidt, Hartmut.

in: BLOOD CANCER J, Jahrgang 9, Nr. 4, 08.04.2019, S. 45.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung

Harvard

Weisel, KC, Scheid, C, Zago, M, Besemer, B, Mai, EK, Haenel, M, Duerig, J, Munder, M, Lindemann, H-W, Seckinger, A, Kunz, C, Benner, A, Hose, D, Jauch, A, Salwender, H & Goldschmidt, H 2019, 'Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial', BLOOD CANCER J, Jg. 9, Nr. 4, S. 45. https://doi.org/10.1038/s41408-019-0206-8

APA

Weisel, K. C., Scheid, C., Zago, M., Besemer, B., Mai, E. K., Haenel, M., Duerig, J., Munder, M., Lindemann, H-W., Seckinger, A., Kunz, C., Benner, A., Hose, D., Jauch, A., Salwender, H., & Goldschmidt, H. (2019). Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial. BLOOD CANCER J, 9(4), 45. https://doi.org/10.1038/s41408-019-0206-8

Vancouver

Weisel KC, Scheid C, Zago M, Besemer B, Mai EK, Haenel M et al. Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial. BLOOD CANCER J. 2019 Apr 8;9(4):45. https://doi.org/10.1038/s41408-019-0206-8

Bibtex

@article{73635fbd3d8f43d4aa6c3313990ef6c7,
title = "Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial",
keywords = "Journal Article",
author = "Weisel, {Katja C} and Christof Scheid and Manola Zago and Britta Besemer and Mai, {Elias K} and Mathias Haenel and Jan Duerig and Markus Munder and Hans-Walter Lindemann and Anja Seckinger and Christina Kunz and Axel Benner and Dirk Hose and Anna Jauch and Hans Salwender and Hartmut Goldschmidt",
note = "Letter",
year = "2019",
month = apr,
day = "8",
doi = "10.1038/s41408-019-0206-8",
language = "English",
volume = "9",
pages = "45",
journal = "BLOOD CANCER J",
issn = "2044-5385",
publisher = "NATURE PUBLISHING GROUP",
number = "4",

}

RIS

TY - JOUR

T1 - Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial

AU - Weisel, Katja C

AU - Scheid, Christof

AU - Zago, Manola

AU - Besemer, Britta

AU - Mai, Elias K

AU - Haenel, Mathias

AU - Duerig, Jan

AU - Munder, Markus

AU - Lindemann, Hans-Walter

AU - Seckinger, Anja

AU - Kunz, Christina

AU - Benner, Axel

AU - Hose, Dirk

AU - Jauch, Anna

AU - Salwender, Hans

AU - Goldschmidt, Hartmut

N1 - Letter

PY - 2019/4/8

Y1 - 2019/4/8

KW - Journal Article

U2 - 10.1038/s41408-019-0206-8

DO - 10.1038/s41408-019-0206-8

M3 - Other (editorial matter etc.)

C2 - 30962424

VL - 9

SP - 45

JO - BLOOD CANCER J

JF - BLOOD CANCER J

SN - 2044-5385

IS - 4

ER -